The Biggest Healthcare Disconnect In Decades - And The Stocks I’m Watching
Healthcare has hit a 26-year relative low, but weakness alone does not make the sector a buy. AI-led capital flows, patent cliffs, IRA pricing pressure, and GLP-1 disruption explain much of the selloff. I prefer selective exposure: picks-and-shovels, AI-driven platforms, and discounted turnarounds…
Published: 2026-05-25 by GNG Research
Tickers: TMO, WST, LLY, ISRG, PFE
It's time for a sector deep dive. Today, we're looking into an industry that hasn't made a lot of friends on Wall Street recently. That sector is healthcare. As the ratio between healthcare stocks (XLV) and the S&P 500 below shows, we're dealing with a 26-year low in the relative performance of healthcare. Less than three years ago, we were at one of the highest levels in decades. Since then, the ratio has erased almost a quarter of a century of relative strength. Source: TradingView (XLV/SPY Ratio) With that said, for generalist investors, this chart looks like a graveyard. But for a macro and equity strategist willing to decouple market mechanics from fundamentals, it is a generational distortion. At least, it could be an opportunity. After all, not everything that's cheap is good. If there's anything I have learned, it's that things are often cheap for a reason. However, when an entire sector has a multi-decade relative low, the baby is almost always thrown out with the bathwater. That's why it's crucial to understand what is going on, why things are happening, and what this means for investment opportunities going forward. In this article, we'll do all of this, as I give you a full sector breakdown and explain which stocks stand out to me, including higher-yielding dividend stocks and low-yield growth stocks. So, let's get to it!
This is a members-only GNG Research article. Read the full analysis with a GNG Research plan.